Skip to main content
. 2021 Nov 11;17(1):78–85. doi: 10.4103/1735-5362.329928

Fig. 2.

Fig. 2

CD44 gene expression in GBM cases. Gene expression in normal vs tumoral tissue is shown by box plots. Gene expression values are demonstrated in Log scale to make the comparison more obvious. (A) CD44 gene expression RNASeq from USCS Xena server based on TCGA GBM cohort data (solid normal tissue: n = 5; primary tumor: n = 155; recurrent tumor: n = 13); (B) CD44 gene expression RNASeq in The Cancer Immunome Atlas (TCIA) server based on TCGA datasets (tumor tissue: n = 156; normal: n = 5); (C) CD44 gene expression in GEPIA 2.0 database based on TCGA and GTEx GBM datasets (tumor samples: n = 163; normal samples: n = 207); (D) gene expression of CD44 in TIMER 2.0 database based on TCGA datasets (tumor tissue: n = 153; normal tissue: n = 5). GMB, Glioblastoma multiforme; FPKM, fragment per kilobase of transcript per million mapped reads, a normalized measure of gene expression; TPM, transcripts per million, a normalized measure of gene expression.